<DOC>
	<DOC>NCT01071720</DOC>
	<brief_summary>The purpose of this study is to assess the effect of food on the pharmacokinetic characteristics of CKD-501 in healthy subject. And, secondarily, pharmacokinetic characteristics of the main metabolites will be identified.</brief_summary>
	<brief_title>The Effect of Food on the Pharmacokinetic Characteristics of CKD-501</brief_title>
	<detailed_description>Healthy volunteers are administrated single-dose (CKD-501 1mg), two treatment(fed vs. fasting), two-period, two sequence crossover. Every time before and after each medication, PK parameters and safety of CKD-501 1mg is performed using a blood sample and conducting some tests respectively.</detailed_description>
	<criteria>Between 20 aged and 45 aged in healthy adults Weight more than 45kg, IBW 20% within the range Agreement with written informed consent Subject has symptoms of acute disease within 28 days of starting administration of investigational drug Subject with known for history(such as inflammatory gastrointestinal disease, gastric or duodenal ulcer, liver diseases and so on) with affect the ADME of drug Clinically significant, active gastrointestinal system, cardiovascular system, pulmonary system, renal system, endocrine system, blood system, digestive system, central nervous system, mental disease or malignancy disease Inadequate subject by medical examination(medical history, physical examination, ECG, laboratory test) within 28 days of starting administration of investigational drug Inadequate result of laboratory test AST(SGOT) or ALT(SGPT) &gt; 1.25 x upper limit of normal range Total bilirubin &gt; 1.5 x upper limit of normal range Clinically significant allergic disease(Except for mild allergic rhinitis seems to be not need for medication) Subject with known for hypersensitivity reactions to glitazone Previously participated in other trial within 60 days Treatment with dugmedicated induction/inhibition metabolic enzyme such as barbiturates within 1 month or with may affect the clinical trial within 10 days Subject takes an abnormal meal which affect the ADME of drug Not able to taking the institutional standard meal Previously make whole blood donation within 60 days or component blood donation within 20 days Continued to be taking caffeine (caffeine &gt; 5 cup/day), drinking(alcohol &gt; 30 g/day) or during clinical trials can not be drunk or severe heavy smoker (cigarette &gt; 10 cigarettes per day) An impossible one who participates in clinical trial by investigator's decision including for reason of laboratory test result Subject who not practice contraception during clinical trial or pregnant women(including positive pregnancy test) or nursing mothers</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Healthy subjects</keyword>
</DOC>